Transforming growth factor β1 (TGF-β1) is a preoperative prognostic indicator in advanced gastric carcinoma

British Journal of Cancer

Volumn 78, Issue 10, 1998, Pages 1373-1378

  Nakamura, M ^a   Katano, M ^a   Kuwahara, A ^a   Fujimoto, K ^a   Miyazaki, K ^a   Morisaki, T ^b   Mori, M ^a  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Biopsy specimens; High risk group; Reverse transcriptase polymerase chain reaction

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH CARCINOMA;

EID: 0031761121     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.687     Document Type: Article

References (49)

1. Albino AP, Davis BM and Nanus DM (1991) Introduction of growth factor mRNA expression in human malignant melanoma: markers of transformation. Cancer Res 51: 4815-4820
2. Anzano MA, Roberts AB, De Larco JE, Wakefield LM, Assoian RK, Roche NS, Smith JM, Lazarus JE and Sporn MB (1985) Increased secretion of type beta transforming growth factor accompanies viral transformation of cells. Mol Cell Biol 5: 242-247
3. Assoian RK, Komoriyama A, Meyers CA, Miller DM and Sporn MB (1983) Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258: 7155-7160
4. Braun L, Gruppuso P, Mikumo R and Fausto N (1990) Transforming growth factor β1 in liver carcinogenesis: messenger RNA expression and growth effects. Cell Growth Diff 1: 103-111
5. Chromczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
6. Coffey RJ Jr, Sipes NJ, Bascom CC, Graves-Deal R, Pennington CY, Weissman BE and Moses HL (1988) Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res 48: 1596-1602
7. Cui W, Kemp CJ, Duffie E, Balmain A and Akhurst RJ (1994) Lack of transforming growth factor-β1 expression in benign skin tumours of p53null mice is prognostic for a high risk of malignant conversion. Cancer Res 54: 5831-5836
8. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB and Goeddel DV (1985) Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701-705
9. Eklov S, Funa K, Nordgren H, Olofsson A, Kanzaki T, Miyazono K and Nilsson S (1993) Lack of latent transforming growth factor β binding protein in malignant, but not benign prostatic tissue. Cancer Res 53: 3193-3197
10. Fowlis DJ, Flanders KC, Duffie E, Balmain A and Akhurst RJ (1992) Discordant transforming growth factor β1 RNA and protein localizations during chemical carcinogenesis of the skin. Cell Growth Diff 3: 81-91
11. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI and Korc M (1993) Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105: 1846-1856
12. Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S and Yuspa SH (1993) Loss of expression of transforming growth factor β in skin and skin tumours is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 90: 6076-6080
13. Gomella LG, Sargent ER, Wade TP, Anglard T, Linehan WM and Kasid A (1984) Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factors α and β1 in renal cell carcinoma. Cancer Res 49: 6972-6975
14. Gorsch SM, Memoli VA, Stukel TA, Gold LI and Arrick BA (1992) Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res 52: 6949-6952
15. Hayashi N, Ito I, Yanagisawa A, Kato Y, Nakamori S, Imaoka S, Watanabe H, Ogawa M and Nakamura Y (1995) Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 345: 1257-1259
16. Hirayama D, Fujimori T, Satonaka K, Nakumura T, Kitazawa S, Horio M, Maeda S and Nagasako K (1992) Immunohistochemical study of epidermal growth factor and transforming growth factor-β in the penetrating type of early gastric cancer. Hum Pathol 23: 681-685
17. Hoosein NM, Brattain DE, Mcknight MK, Levine AE and Brattain MG (1987) Characterization of the inhibitory effects of transforming growth factor β on a human colon carcinoma cell line. Cancer Res 47: 2950-2954
18. Ito M, Yasui W, Kyo E, Yokozaki H, Nakayama H, Ito H and Tahara E (1992) Growth inhibition of transforming growth factor β on human gastric carcinoma cells: receptor and postreceptor signaling. Cancer Res 52: 295-300
19. Japanese Research Society for Gastric Cancer (1995) Japanese Classification of Gastric Carcinoma. Kanehara & Co: Tokyo
20. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M and Stettner HM (1995) A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 76: 1302-1312
21. Jirtle RL, Haag JD, Ariazi EA and Gould MN (1993) Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor β1 levels during monoterpene-induced regression of mammary tumours. Cancer Res 53: 3849-3852
22. Kehrl JH, Taylor A, Kim SJ and Fauci AS (1991) Transforming growth factor-β is a potent negative regulator of human lymphocytes. Ann NY Acad Sci 628: 345-353
23. Kim SJ, Glick A, Sporn MB and Roberts AB (1989a) Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem 264: 402-408
24. Kim SJ, Jeang KT, Glick AB, Sporn MB and Roberts AB (1989b) Promoter sequence of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction. J Biol Chem 264: 7041-7045
25. Kimchi A, Wang XF, Weinberg RA, Cheifetz S and Massague J (1988) Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 240: 196-199
26. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM and Massague J (1990) Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185
27. Leof EB, Proper JA, Goustin AS, Shipley GD, DiCorleto PE and Moses HL (1986) Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA 83: 2453-2457
28. Mackay SL, Yaswen LR, Tarnuzzer RW, Moldawer LL, Bland KI, Copeland III EM and Schultz GS (1995) Colon cancer cells that are not growth inhibited by TGF-β lack functional type I and type II TGF-β receptors. Ann Surg 221: 767-776
29. Maehara Y, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y, Kohnoe S and Sugimachi K (1996) Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 119: 397-402
30. Maruyama K, Gunven P, Okabayashi K, Sasako M and Kinoshita T (1989) Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 210: 596-602
31. Masui T, Wakefield LM, Lechner JF, LaVeck MA Sporn MB and Harris CC (1986) Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 83: 2438-2442
32. Miyazono K, Hellman U, Wernstedt C and Heldin CH (1988) Latent high molecular weight complex of transforming growth factor β1. Purification from human platelets and structural characterization. J Biol Chem 263: 6407-6015
33. Morisaki T, Katano M, Ikubo A, Anan K, Nakamura M, Nakamura K, Sato H, Tanaka M and Torisu M (1996) Immunosuppressive cytokines (IL-10, TGF-β) gene expression in human gastric carcinoma tissues. J Surg Oncol 63: 234-239
34. Moses HL, Yang EY and Pietenpol JA (1990) TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247
35. Nakamura M, Katano M, Fujimoto K and Morisaki T (1997) A new prognostic strategy for gastric carcinoma: mRNA expression of tumour growth-related factors in endoscopic biopsy specimens. Ann Surg 226: 35-42
36. Pepper MS, Belin D, Montesano R, Orci L and Vassalli JD (1990) Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111: 743-755
37. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM and Moses HL (1990) TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777-785
38. Shipley GD, Pittelkow MR, Wille JJ Jr, Scott RE and Moses HL (1986) Reversible inhibition of normal human prokeratinocyte proliferation by type B transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 46: 2068-2071
39. Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H and Hamaoka T (1991) Transforming growth factor-β-induced inhibition of T-cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in tumour-bearing state. J Immunol 146: 1077-1082
40. Tahara E (1990) Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 116: 121-131
41. Tahara E, Sumiyoshi H, Hata J, Yasui W, Taniyama K, Hayashi T, Nagae S and Sakamoto S (1986) Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy. Jpn J Cancer Res 77: 145-152
42. Takanami I, Imamura T, Hashizume T, Kikuchi K, Yamamoto Y and Kodaira S (1994) Transforming growth factor β1 as a prognostic factor in pulmonary adenocarcinoma. J Clin Pathol 47: 1098-1100
43. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL and Rowley DA (1990) A highly immunogenic tumour transfected with a murine transforming growth factor type β-1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87: 1486-1490
44. Travers MT, Barrett-Lee PJ, Berger U, Luqmani YA, Gazet JC, Powles TJ and Coombes RC (1988) Growth factor expression in normal, benign, and malignant breast tissue. Br Med J 296: 1621-1624
45. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y and Matsuzawa Y (1996) High levels of transforming growth factor β1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110: 375-382
46. Ueki N, Nakazato H, Ohkawa T, Ikeda T, Amuro Y, Hada T and Higashino K (1992) Excessive production of transforming growth-factor β1 can play an important role in the development of tumourigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumour growth. Biochim Biophys Acta 1137: 189-196
47. Walker RA and Dearing SJ (1992) Transforming growth factor β1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur J Cancer 28: 641-644
48. Welch DR, Fabra A and Nakajima M (1990) Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87: 7678-7682
49. Yoshida K, Yokozaki H, Nimioto M, Ito H, Ito M and Tahara E (1989) Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int J Cancer 44: 394-398